These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1674950)

  • 41. Tardive dyskinesia and substrates of energy metabolism in CSF.
    Goff DC; Tsai G; Beal MF; Coyle JT
    Am J Psychiatry; 1995 Dec; 152(12):1730-6. PubMed ID: 8526238
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tardive dystonia and ceruletide effects: case report.
    Sugawara M; Iizuka H; Kawana A; Suzuki J
    Prog Neuropsychopharmacol Biol Psychiatry; 1992 Jan; 16(1):127-34. PubMed ID: 1557504
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sulpiride in tardive dyskinesia.
    Schwartz M; Moguillansky L; Lanyi G; Sharf B
    J Neurol Neurosurg Psychiatry; 1990 Sep; 53(9):800-2. PubMed ID: 1978858
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Nithsdale schizophrenia surveys. IX: Akathisia, parkinsonism, tardive dyskinesia and plasma neuroleptic levels.
    McCreadie RG; Robertson LJ; Wiles DH
    Br J Psychiatry; 1992 Jun; 160():793-9. PubMed ID: 1352165
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Possible enhancing effects of diazepam with reserpine in a chronic schizophrenic patient with tardive dyskinesia.
    Bacher NM; Field PB; Elkashef A
    J Clin Psychopharmacol; 1989 Aug; 9(4):312. PubMed ID: 2570090
    [No Abstract]   [Full Text] [Related]  

  • 46. Clonidine therapy for coexisting psychosis and tardive dyskinesia.
    Freedman R; Bell J; Kirch D
    Am J Psychiatry; 1980 May; 137(5):629-30. PubMed ID: 6102849
    [No Abstract]   [Full Text] [Related]  

  • 47. Nilvadipine is effective for chronic schizophrenia in a double-blind placebo-controlled study. off.
    Yamada K; Kanba S; Ashikari I; Ohnishi K; Yagi G; Asai M
    J Clin Psychopharmacol; 1996 Dec; 16(6):437-9. PubMed ID: 8959468
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Polymorphic drug metabolism in schizophrenic patients with tardive dyskinesia.
    Arthur H; Dahl ML; Siwers B; Sjöqvist F
    J Clin Psychopharmacol; 1995 Jun; 15(3):211-6. PubMed ID: 7635999
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tardive dyskinesia and hospital discharge.
    Kucharski LT; Smith JM; Dunn DD
    J Nerv Ment Dis; 1980 Apr; 168(4):215-8. PubMed ID: 6102592
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of adjunctive verapamil administration in chronic schizophrenic patients.
    Bartko G; Horvath S; Zador G; Frecska E
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(3):343-9. PubMed ID: 1677775
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tardive dyskinesia successfully treated with alprazolam.
    Jordan HW; Williams BC
    J Natl Med Assoc; 1990 Sep; 82(9):673-5. PubMed ID: 2213917
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of tardive dyskinesia with dihydrogenated ergot alkaloids (hydergine): a pilot study.
    Mohamed SN; Kazarian S; Merskey H; Thompson MG
    Can J Psychiatry; 1980 Jun; 25(4):325-8. PubMed ID: 6103748
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tardive dyskinesia in young adults.
    Tarsy D; Granacher R; Bralower M
    Am J Psychiatry; 1977 Sep; 134(9):1032-4. PubMed ID: 409302
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The combination of amantadine and neuroleptics plus time may cure tardive dyskinesia.
    Ankenman R
    J Neuropsychiatry Clin Neurosci; 1989; 1(1):96-7. PubMed ID: 2577721
    [No Abstract]   [Full Text] [Related]  

  • 55. Aripiprazole Combined with Lamotrigine in the Treatment of a Treatment-Resistant Schizophrenic Patient with Tardive Dyskinesia and Supersensitivity Psychosis.
    Peretti CS; Chouinard G
    Psychother Psychosom; 2019; 88(5):313-314. PubMed ID: 31291629
    [No Abstract]   [Full Text] [Related]  

  • 56. Tardive dyskinesia: two-year recovery.
    Seeman MV
    Compr Psychiatry; 1981; 22(2):189-92. PubMed ID: 6111416
    [No Abstract]   [Full Text] [Related]  

  • 57. Lack of clinically significant improvement of patients with tardive dyskinesia following phosphatidylcholine therapy.
    Domino EF; May WW; Demetriou S; Mathews B; Tait S; Kovacic B
    Biol Psychiatry; 1985 Nov; 20(11):1189-96. PubMed ID: 2864962
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Calcium channel blockers for tardive dyskinesia in geriatric psychiatric patients.
    Kushnir SL; Ratner JT
    Am J Psychiatry; 1989 Sep; 146(9):1218-9. PubMed ID: 2764182
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phenylethylamine-like properties of baclofen.
    Wolf ME; Keener S; Mathis P; Mosnaim AD
    Neuropsychobiology; 1983; 9(4):219-22. PubMed ID: 6646393
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pyridoxine improves drug-induced parkinsonism and psychosis in a schizophrenic patient.
    Sandyk R; Pardeshi R
    Int J Neurosci; 1990 Jun; 52(3-4):225-32. PubMed ID: 2269609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.